• eBrevia

  Participated · Seed · Nov 2014

  eBrevia provides enterprise contract review and analysis software that leverages machine learning and natural language processing to extract concepts and summarize key legal provisions from contracts. The platform is pre-trained on legal concepts and also allows clients to teach the system to extract nearly unlimited custom categories of information. Common use cases cited include due diligence, contract management, lease abstraction, and document drafting. The company’s technology was developed at Columbia University; eBrevia was founded in 2011 and is based in Stamford, CT with an office in New York, NY. Financially, eBrevia has received a strategic investment from Donnelley Financial Solutions and entered a formal integration to embed its contract analytics into DFIN’s Venue Deal Solutions suite. The partnership is intended to increase speed and accuracy of contract review for deal teams and to expand eBrevia’s sales and development reach through DFIN’s Venue Contract Analytics. eBrevia has developed machine learning technology to bring accuracy and efficiency to contract review and analytics. Its software is used by corporate lawyers, in-house law departments, financial institutions and commercial real estate companies. In addition to transaction-based applications, customers can use the product to extract and track obligations in existing contracts. The company was founded in 2011 by Ned Gannon, Adam Nguyen and Jacob Mundt and is based in Stamford, CT. eBrevia is a portfolio company of Columbia Technology Ventures. In November 2014 the company raised $1.5M in seed funding. eBrevia is a Stamford, Conn.-based company commercializing natural language processing technology for the legal sector. Developed at Columbia University, its software uses machine learning to extract and summarize legal provisions from a wide array of documents. The company's first product targets legal due diligence by analyzing documents and extracting and summarizing key provisions based on user specifications. Its target customers include law firms, in-house legal departments and investment firms. Financially, eBrevia raised $150K in funding from Connecticut Innovations' Pre-Seed Fund. In 2012 it previously received $25K from CI's TechStart Accelerator Program. The company is led by CEO Ned Gannon, COO Adam Nguyen, and CTO Jacob Mundt.

• CMD Bioscience

  Participated · Series A · Dec 2012

  CMDBioscienceSM specializes in computer-enabled analysis, modeling and design of therapeutic protein-peptide interactions. It provides a proprietary validated discovery platform, CMDInventusSM, which allows partner organizations to identify novel peptide hits, understand the structural basis of protein-peptide interactions, and rationally optimize peptide leads. Led by CEO Joseph Audie, Ph.D., the company positions CMDInventusSM as a partner-focused discovery tool for peptide therapeutic development. CMDBioscienceSM is a tenant in the CI-managed CTech@Science Park incubator at Yale in New Haven, Connecticut. Financially, the company raised $1M in a Series A round, with Connecticut Innovations contributing $500k and additional participation from LaunchCapital, Enhanced Capital Connecticut, the Mohegan Tribe and an individual investor. Following the financing, CI's managing director of investments, Daniel Wagner, joined CMDBioscienceSM's board of directors.

No current team members are available.